Antimicrobial multidrug resistance in the era of COVID-19: a forgotten plight?

Eric Pelfrene1, Radu Botgros2, Marco Cavaleri2

  • 1Office of Vaccines and Therapies for Infectious Diseases, Human Medicines Division, European Medicines Agency, 1083 HS, Amsterdam, The Netherlands. eric.pelfrene@ema.europa.eu.

Abstract

Insights

Antimicrobial resistance (AMR) is a growing threat, potentially worsened by COVID-19. Integrated strategies and global collaboration, using a "One Health" approach, are crucial to combat AMR.

Area of Science:

  • Public Health
  • Infectious Diseases
  • Global Health Security

Background:

  • Antimicrobial resistance (AMR) presents a significant global challenge, exacerbated by the COVID-19 pandemic.
  • The pandemic diverted resources from antimicrobial stewardship and led to increased antibiotic use, potentially worsening AMR.
  • Deteriorating economic conditions and poverty also contribute to the escalating AMR threat.

Discussion:

  • This paper reviews key antimicrobial resistance countermeasures and reiterates priorities for addressing the issue.
  • It emphasizes the necessity of a "One Health" approach, integrating human, animal, and environmental health for effective AMR control.
  • The European Medicines Regulatory Network's initiative to enhance AMR measures is highlighted as a significant step.

Key Insights:

  • Global collaboration is essential for tackling emerging health threats, with the "One Health" framework providing a model.
  • An integrated preparedness strategy is vital for effectively managing the public health peril of AMR.
  • Strengthening regulatory measures and fostering international cooperation are critical components of AMR counteraction.

Outlook:

  • Continued focus on integrated strategies and global partnerships is necessary to mitigate the AMR crisis.
  • The "One Health" approach offers a sustainable blueprint for addressing interconnected health challenges.
  • Proactive and collaborative efforts are paramount to safeguard public health against antimicrobial resistance.

Related Concept Videos

Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
803
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
772
Antibiotic Selection00:57

Antibiotic Selection

Overview
57.5K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
5.8K
Antimicrobial Proteins01:23

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
12.4K